Paper40756366
Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention.
Wu H and 5 others. Theranostics, 2025. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention. Papers, record 40756366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40756366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Focusing on the interplay between tumor-associated macrophages and tumor microenvironment: from mechanism to intervention.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Tumor-Associated Macrophages | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Immunotherapy | |
| Animals | |
| Extracellular Matrix | |
| Cancer-Associated Fibroblasts |
Source PubMed
References227
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36948193 | T helper 2 cells control monocyte to tissue-resident macrophage differentiation during nematode infection of the pleural cavity. | Immunity | 2023 | https://conductscience.org/library/papers/36948193 | PubMed |
| 2 | 34012454 | Cholesterol-Induced M4-Like Macrophages Recruit Neutrophils and Induce NETosis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34012454 | PubMed |
| 3 | 31167148 | Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles. | Cell Rep | 2019 | https://conductscience.org/library/papers/31167148 | PubMed |
| 4 | 37140602 | Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors. | Cancer Chemother Pharmacol | 2023 | https://conductscience.org/library/papers/37140602 | PubMed |
| 5 | 33451977 | Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33451977 | PubMed |
| 6 | 33450585 | Regulation of extracellular matrix assembly and structure by hybrid M1/M2 macrophages. | Biomaterials | 2021 | https://conductscience.org/library/papers/33450585 | PubMed |
| 7 | 25359998 | The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. | J Leukoc Biol | 2015 | https://conductscience.org/library/papers/25359998 | PubMed |
| 8 | 31735641 | Cancer-Derived Succinate Promotes Macrophage Polarization and Cancer Metastasis via Succinate Receptor. | Mol Cell | 2020 | https://conductscience.org/library/papers/31735641 | PubMed |
| 9 | 34804043 | Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes. | Front Immunol | 2021 | https://conductscience.org/library/papers/34804043 | PubMed |
| 10 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 11 | 31695806 | Advances in Engineering Cells for Cancer Immunotherapy. | Theranostics | 2019 | https://conductscience.org/library/papers/31695806 | PubMed |
| 12 | 38409190 | Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF. | Nat Commun | 2024 | https://conductscience.org/library/papers/38409190 | PubMed |
| 13 | 6828888 | Regulation of the macrophage content of neoplasms by chemoattractants. | Science | 1983 | https://conductscience.org/library/papers/6828888 | PubMed |
| 14 | 28210073 | Macrophages as Key Drivers of Cancer Progression and Metastasis. | Mediators Inflamm | 2017 | https://conductscience.org/library/papers/28210073 | PubMed |
| 15 | 31775862 | Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. | J Immunother Cancer | 2019 | https://conductscience.org/library/papers/31775862 | PubMed |
| 16 | 30664738 | Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30664738 | PubMed |
| 17 | 27339708 | The role of myeloid cells in cancer therapies. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27339708 | PubMed |
| 18 | 19479998 | Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. | Int J Cancer | 2009 | https://conductscience.org/library/papers/19479998 | PubMed |
| 19 | 34209703 | Macrophage Polarization States in the Tumor Microenvironment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34209703 | PubMed |
| 20 | 18392134 | Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. | Neoplasia | 2008 | https://conductscience.org/library/papers/18392134 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787504 | The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials. | Front Immunol | 2026 | https://conductscience.org/library/papers/42787504 | PubMed |
| 42514862 | Anthraquinone-Loaded Liposomes for TAM Reprogramming in Triple-Negative Breast Cancer: Mechanistic Rationale, Delivery Logic, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514862 | PubMed |
| 42459682 | MCT4 drives HCC progression by activating MMPs and polarizing M2 macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459682 | PubMed |
| 42394904 | Engineering the tumor immune landscape: Translating non-invasive physical stimulation into tumor-associated macrophage-targeted cancer immunotherapy. | Bioeng Transl Med | 2026 | https://conductscience.org/library/papers/42394904 | PubMed |
| 42368560 | Targeting cytokine/chemokine signaling to convert immunologically cold tumors into hot: Emerging strategies in cancer immunotherapy. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368560 | PubMed |
| 42317307 | The link between macrophage polarization and response to radiotherapy in cancers: mechanisms and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317307 | PubMed |
| 42291208 | The competition of amino acid among tumors, tumor-associated macrophages and T cells based on metabolic reprogramming. | iScience | 2026 | https://conductscience.org/library/papers/42291208 | PubMed |
| 42212312 | Targeting Tumor-Associated Macrophages to Reshape the Immuno-Mechanical Landscape: Molecular Mechanisms and Therapeutic Strategies. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42212312 | PubMed |
| 42169648 | Polysaccharides: Natural candidates for targeting immunometabolic regulation in hepatocellular carcinoma (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42169648 | PubMed |
| 42143355 | SLAMF8 promotes tumor growth of gastric cancer by enhancing M2 polarization of tumor-associated macrophages. | J Transl Med | 2026 | https://conductscience.org/library/papers/42143355 | PubMed |
| 42141299 | The ATP-adenosine axis as a driver of tumor-associated macrophage reprogramming in colorectal cancer: mechanistic insights into immune evasion and therapeutic vulnerabilities. | Purinergic Signal | 2026 | https://conductscience.org/library/papers/42141299 | PubMed |
| 41953398 | FCGR2B + Macrophages as a Critical Node Linking Ferroptosis and Immunosuppression: A Multiomics Framework for Prognosis and Therapy in High-Grade Serous Ovarian Cancer. | Hum Mutat | 2026 | https://conductscience.org/library/papers/41953398 | PubMed |
| 41799204 | Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking. | Theranostics | 2026 | https://conductscience.org/library/papers/41799204 | PubMed |
| 41769787 | Research Progress on Tumor-Associated Macrophages and PD-1/PD-L1 Inhibitors in Advanced Colorectal Cancer. | Cancer Control | 2026 | https://conductscience.org/library/papers/41769787 | PubMed |
| 41704419 | Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41704419 | PubMed |
| 41619135 | A novel signature of palmitoylation for predicting prognosis and therapeutic response of hepatocellular carcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41619135 | PubMed |
| 41540625 | Migration and invasion inhibitory protein inhibits M2 macrophage polarization to suppress colorectal cancer progression through the STING-NFκB2-IL10 axis. | Cancer Biol Med | 2026 | https://conductscience.org/library/papers/41540625 | PubMed |
| 41520491 | CTSB-positive tumor-associated macrophages shape prognosis and therapeutic response in lung adenocarcinoma. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41520491 | PubMed |
| 41425545 | SPP1+ macrophages in tumor immunosuppression: mechanisms and therapeutic implications. | Front Immunol | 2025 | https://conductscience.org/library/papers/41425545 | PubMed |
| 41383981 | Integrated diagnostic evaluation of multiple malignant neoplasms via 99mTc-MDP three-phase bone imaging: A case report. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41383981 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40756366
GET https://conductscience.org/api/papers/v1/40756366/references?page=2